Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis
Author:
Affiliation:
1. The First School of Clinical Medical Sciences Guangzhou University of Chinese, Medicine Guangzhou China
2. Department of Endocrinology The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou China
Funder
Guangzhou University of Chinese Medicine
National Natural Science Foundation of China
Publisher
Wiley
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13814
Reference32 articles.
1. The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of Latent autoimmune diabetes of adults (LADA): Evidence based on available data
2. Latent autoimmune diabetes of the adult: current knowledge and uncertainty
3. Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult)
4. A Global Perspective of Latent Autoimmune Diabetes in Adults
5. Adult-onset autoimmune diabetes: current knowledge and implications for management
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness and safety of glucose-lowering drugs as an adjunct to insulin therapy in Chinese patients with type 1 diabetes: a retrospective, observational study;Endocrine;2024-09-09
2. The efficacy and safety of Diptptidyl peptidase-4 inhibitors combined with insulin in patients with autoimmune diabetes: A updated meta-analysis;Endocrine and Metabolic Science;2024-06
3. Sitagliptin Induces Tolerogenic Human Dendritic Cells;International Journal of Molecular Sciences;2023-11-27
4. A systematic review exploring the mechanisms by which citrus bioflavonoid supplementation benefits blood glucose levels and metabolic complications in type 2 diabetes mellitus;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-11
5. Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes;Frontiers in Endocrinology;2023-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3